Opthea Company
Opthea Limited (formerly Circadian Technologies) is a public Australian biotechnology company developing novel biologic therapies for the treatment of eye diseases. Opthea's lead compound, OPT-302, blocks two members of the vascular endothelial growth fa
Technology:
NeuroTech
Industry:
Biopharma, Biotechnology, Health Care, Life Science, Medical Device, Pharmaceutical
Headquarters:
South Yarra, Victoria, Australia
Founded Date:
2012-01-01
Employees Number:
11-50
Funding Status:
IPO
Register and Claim Ownership